Diabetes technology

Continuous Glucose Monitoring Initiation Is Associated With Reduced Mortality in Older-Onset Type 1 Diabetes Patients: A Target Trial Emulation Study Within the Veterans Health Administration

Diabetes CarePublished Target trial emulation study

Authors' conclusion

In this large TTE of CGM initiation in older T1D patients, CGM use was associated with reduced risk for all-cause mortality.

Study context

Population
Adult T1D patients with second endocrine visit (time zero) in 2017–2020, Veterans Health Administration8,423 cloned to both strategies
Participants
1,039 vs 7,399
Exposure
Continuous glucose monitoring (CGM) initiation vs no CGM
  • CGMn = 1,039
  • Non-CGMn = 7,399reference
Outcome
All-cause mortality
Follow-up
1-4 years
Methodological detailsobservational health records, clone-censor-weight design, inverse probability weights, 6-month grace period, negative control outcomes
  • Observational health records
  • Clone-censor-weight design
  • Inverse probability weights
  • 6-month grace period
  • Negative control outcomes

Main finding

As reported in the abstract

CGM vs Non-CGMAdjusted relative risk (95% CI)
Lower bound of range over follow-up
0.90(0.71–0.97)
Upper bound of range over follow-up
0.84(0.72–0.97)

Observational data: associations, not effects.

Further findings

Mortality with different grace periods (3 or 9 months)

Similar risk ratios were seen with different grace periods

Mortality by subgroup

Age >65 years or not on insulin pumps appeared to have greater benefit
Effects did not vary by HbA1c, race or ethnicity, or frailty

Incident nondiabetes (negative control) outcomes

Risk ratios did not differ between groups, incl. outpatient or inpatient musculoskeletal or gastrointestinal conditions

Original publication

Continuous Glucose Monitoring Initiation Is Associated With Reduced Mortality in Older-Onset Type 1 Diabetes Patients: A Target Trial Emulation Study Within the Veterans Health Administration. Diabetes Care. Published 19 June 2026. doi:10.2337/dc26-0425

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.